PECAM1 and neoplasm: Histopathological and immunohistochemical analyses assessed changes in tumour tissue, cell proliferation (Ki-67), angiogenesis (CD31), immune cell infiltration (CD8+ T cells), regulatory T cells (FoxP3+), and programmed death ligand 1 (PD-L1) expression.